• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital.处于风暴中心:城市教学医院药剂师在新冠疫情期间药物安全中的作用
Pharmacy (Basel). 2020 Nov 21;8(4):225. doi: 10.3390/pharmacy8040225.
2
Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis.2019冠状病毒病中严重急性呼吸综合征冠状病毒2的眼部表现、合并症及结膜检测:一项系统评价和荟萃分析
Taiwan J Ophthalmol. 2020 Sep 16;10(3):153-166. doi: 10.4103/tjo.tjo_53_20. eCollection 2020 Jul-Sep.
3
Evaluation of the exposure risk of SARS-CoV-2 in different hospital environment.不同医院环境中新型冠状病毒暴露风险评估。
Sustain Cities Soc. 2020 Oct;61:102413. doi: 10.1016/j.scs.2020.102413. Epub 2020 Jul 22.
4
Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.一种广谱抗冠状病毒药物对SARS-CoV-2主要蛋白酶的抑制作用的结构基础
Am J Cancer Res. 2020 Aug 1;10(8):2535-2545. eCollection 2020.
5
Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).一名确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)且疑似史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症(SJS/TEN)的有症状患者出现两次假阴性检测结果。
Cureus. 2020 May 19;12(5):e8198. doi: 10.7759/cureus.8198.
6
Adapting Lessons From SARS for the COVID-19 Pandemic-Perspectives From Radiology Nursing in Singapore.借鉴非典经验应对新冠疫情——新加坡放射护理视角
J Radiol Nurs. 2020 Sep;39(3):164-167. doi: 10.1016/j.jradnu.2020.06.008. Epub 2020 Jun 26.
7
Drug Shortage and Critical Medication Inventory Management at a Children's Hospital During the COVID-19 Pandemic.新冠疫情期间一家儿童医院的药品短缺与关键药品库存管理
J Pediatr Pharmacol Ther. 2021;26(1):21-25. doi: 10.5863/1551-6776-26.1.21. Epub 2021 Jan 4.
8
Pharmacy Leadership Amid the Pandemic: Maintaining Patient Safety During Uncertain Times.疫情期间的药学领导力:在不确定时期维护患者安全
Hosp Pharm. 2022 Jun;57(3):323-328. doi: 10.1177/00185787211037545. Epub 2021 Aug 5.
9
[The role of the pharmacist in the detection of Covid-19].[药剂师在新冠病毒检测中的作用]
Actual Pharm. 2020 Dec;59(601):41-43. doi: 10.1016/j.actpha.2020.10.023. Epub 2020 Oct 23.
10
Pharmacy Challenges in Cardiac Patient Care During the COVID-19 Pandemic: Lessons Learnt For the Future.COVID-19大流行期间心脏病人护理中的药学挑战:未来的经验教训
Card Fail Rev. 2023 Feb 2;9:e03. doi: 10.15420/cfr.2022.20. eCollection 2023 Feb.

引用本文的文献

1
Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain.第一波和第四波疫情期间治疗新冠症状药物的短缺情况:对奥地利、意大利和西班牙上报至登记处的通报分析
Pharmacy (Basel). 2023 Jul 21;11(4):120. doi: 10.3390/pharmacy11040120.

本文引用的文献

1
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.新型冠状病毒肺炎患者静脉血栓栓塞症的预防、诊断和治疗:CHEST 指南和专家报告。
Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2.
2
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
3
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
4
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.新型冠状病毒病 2019 感染相关静脉血栓栓塞症的预防与治疗:指南出台前的共识声明。
Thromb Haemost. 2020 Jun;120(6):937-948. doi: 10.1055/s-0040-1710019. Epub 2020 Apr 21.
5
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.在新型冠状病毒肺炎(COVID-19)的治疗中应注意静脉血栓栓塞的预防。
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会(ESC)与欧洲呼吸学会(ERS)合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
9
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms.血栓炎症:治疗性靶向凝血和其他宿主防御机制的挑战。
Blood. 2019 Feb 28;133(9):906-918. doi: 10.1182/blood-2018-11-882993. Epub 2019 Jan 14.
10
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南:住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.

处于风暴中心:城市教学医院药剂师在新冠疫情期间药物安全中的作用

In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital.

作者信息

Kanaan Abir O, Sullivan Karyn M, Seed Sheila M, Cookson Nathan A, Spooner Linda M, Abraham George M

机构信息

School of Pharmacy Worcester/Manchester, MCPHS University, Worcester, MA 01608, USA.

Saint Vincent Hospital, Worcester, MA 01608, USA.

出版信息

Pharmacy (Basel). 2020 Nov 21;8(4):225. doi: 10.3390/pharmacy8040225.

DOI:10.3390/pharmacy8040225
PMID:33233363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712060/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies to various case questions, describing some of the challenges faced by practitioners at an urban teaching hospital during the COVID-19 pandemic. The strategies suggested can be explored at other institutions.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是导致冠状病毒病(COVID-19)大流行的病毒,它给从业者带来了复杂的临床情况以及相互矛盾且稀缺的数据,以支持治疗策略。由于药物短缺、用药流程改变、经济损失以及工作人员接触病毒,这场大流行也给各机构带来了压力。本文提供了由药剂师主导的针对各种病例问题的建议和策略,描述了一家城市教学医院的从业者在COVID-19大流行期间所面临的一些挑战。所建议的策略可供其他机构探讨。